Hospira (HSP +7.2%) shares power ahead after the specialty pharmaceutical company's Q4 adjusted...

|By:, SA News Editor

Hospira (HSP +7.2%) shares power ahead after the specialty pharmaceutical company's Q4 adjusted EPS from ongoing operations came in at $0.51 and revenues hit $1.01B, both topping expectations. CEO Michael Ball says a factory cited for manufacturing problems had reopened and was nearing previous production levels.